Eloxx Pharmaceuticals, Inc.
ELOX
Revenue
0.00
▼-200.00k▼-100.00%
12 Months ChangeAssets
6.04M
▲49.00k▲0.8176%
3 Months ChangeLiabilities
26.09M
▲1.50M▲6.10%
3 Months ChangeFree Cash Flow
-6.81M
▲2.69M▲28.29%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-17
Form 8-K
ID: 0001104659-24-109521
2024-07-16
Form 8-K
ID: 0001104659-24-080251
2024-03-29
Form 8-K
ID: 0001104659-24-041148
2024-03-14
Form 8-K
ID: 0001104659-24-034529
2024-01-09
Form 8-K
ID: 0001104659-24-002631
2023-12-28
Form 8-K
ID: 0001104659-23-130052
2023-12-15
Form 8-K
ID: 0001104659-23-126400
2023-11-13
Form 8-K
ID: 0001104659-23-117308
2023-11-13
Form 10-Q
ID: 0000950170-23-062940
2023-10-16
Form 8-K
ID: 0001104659-23-109423